Alopecia Treatment Market by Drug Type (Minoxidil, Finasteride, and Other Drug Types), Indication (Androgenic Alopecia, Alopecia Areata, Alopecia Totalis, and Others), and Distribution Channel (Hospitals Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 20192026
- Published Date: 2020-10-06
- Report ID: 1398
- Pages: 243
-
Format:
The global alopecia treatment market was valued at $2,736 million in 2018, and is projected to reach $3,935 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Alopecia is a term used to describe extreme hair loss or hair damage under certain dietary issues and medical conditions. It is a common autoimmune disease, which causes bald spots resulting in partial or complete hair loss. It can affect persons of all gender and at any stage of life, it commonly affects mid-aged generation. Various hair transplant therapies and drugs can be used for the treatment of alopecia condition. Treatment of alopecia condition can be carried out using drugs such as minoxidil, finasteride, and other drugs.
Significant increase in prevalence of chronic diseases such as hypertension, arthritis, Polycystic Ovary Syndrome (PCOS), and depression; rise in geriatric population; hormonal imbalance; high level of stress; increase in consumption of alcohol & tobacco, change in food habits, and increase in prevalence of chemotherapy induced alopecia fuel the growth of the alopecia treatment market. Moreover, rise in awareness programs for alopecia treatment & management; increase in prevalence of alopecia conditions such as androgenic alopecia, alopecia areata, alopecia totalis, and others; and genetic factors might contribute toward rise in incidences of alopecia among both men & women are other factors that contribute toward the growth of the market. However, poor demand for alopecia treatment drugs in underdeveloped countries are expected to hinder the growth of the market.
The alopecia treatment market is segmented into drug type, indication, distribution channel, and region. By drug type, the market is categorized into minoxidil, finasteride, and other drug types. The indication covered in the study include androgenic alopecia, alopecia areata, alopecia totalis, and others. Depending on distribution channel, the market is classified into hospitals pharmacies, drug stores & retail pharmacies, and online pharmacies. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Drug Type
Minoxidil
Finasteride
Other Drug Types
By Indication
Androgenic Alopecia
Alopecia Areata
Alopecia Totalis
Others
By End User
Hospitals Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Capillus, LLC
Cipla Inc.
Daiichi Sankyo Company, Limited
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co., Inc.
Sun Pharmaceutical Industries Ltd.
Transitions Hair
Vitabiotics Ltd.
Vita-Cos-Med Klett-Loch GmbH
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Dr. Reddy's Laboratories
Concert Pharmaceuticals Inc.
Aclaris Therapeutics, Inc.
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.3. PorterS Five Force Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase In Chronic Diseases To Lead To Hair Loss
3.4.1.2. Surge In Global Geriatric Population
3.4.1.3. Increase In Government Expenditure On Healthcare
3.4.2. Restraint
3.4.2.1. Poor Demand In Under Developed Countries
3.4.3. Opportunities
3.4.3.1. Growth Opportunities In Emerging Markets
3.4.4. Impact Analysis
Chapter 4: Alopecia Treatment Market, By Drug Type
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Minoxidil
4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country
4.3. Finasteride
4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4. Other Drug Types
4.4.1. Key Market Trends And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country
Chapter 5: Alopecia Treatment Market, By Indication
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Androgenic Alopecia
5.2.1. Market Size And Forecast
5.2.2. Market Analysis, By Country
5.3. Alopecia Areata
5.3.1. Market Size And Forecast
5.3.2. Market Analysis, By Country
5.4. Alopecia Totalis
5.4.1. Market Size And Forecast
5.4.2. Market Analysis, By Country
5.5. Others
5.5.1. Market Size And Forecast
5.5.2. Market Analysis, By Country
Chapter 6: Alopecia Treatment Market, By Distribution Channel
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Hospitals Pharmacies
6.2.1. Market Size And Forecast
6.2.2. Market Analysis, By Country
6.3. Drug Stores & Retail Pharmacies
6.3.1. Market Size And Forecast
6.3.2. Market Analysis, By Country
6.4. Online Pharmacies
6.4.1. Market Size And Forecast
6.4.2. Market Analysis, By Country
Chapter 7: Alopecia Treatment Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Alopecia Treatment Market, By Drug Type
7.2.2.1.2. U.S. Alopecia Treatment Market, By Indication
7.2.2.1.3. U.S. Alopecia Treatment Market, By Distribution Channel
7.3. North America
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country
7.3.2.1. U.S.
7.3.2.1.1. U.S. Alopecia Treatment Market, By Drug Type
7.3.2.1.2. U.S. Alopecia Treatment Market, By Indication
7.3.2.1.3. U.S. Alopecia Treatment Market, By Distribution Channel
7.3.2.2. Canada
7.3.2.2.1. Canada Alopecia Treatment Market, By Drug Type
7.3.2.2.2. Canada Alopecia Treatment Market, By Indication
7.3.2.2.3. Canada Alopecia Treatment Market, By Distribution Channel
7.3.2.3. Mexico
7.3.2.3.1. Mexico Alopecia Treatment Market, By Drug Type
7.3.2.3.2. Mexico Alopecia Treatment Market, By Indication
7.3.2.3.3. Mexico Alopecia Treatment Market, By Distribution Channel
7.3.3. North America Market Size And Forecast, By Drug Type
7.3.4. North America Market Size And Forecast, By Indication
7.3.5. North America Market Size And Forecast, By Distribution Channel
7.4. Europe
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.2.1. Germany
7.4.2.1.1. Germany Alopecia Treatment Market, By Drug Type
7.4.2.1.2. Germany Alopecia Treatment Market, By Indication
7.4.2.1.3. Germany Alopecia Treatment Market, By Distribution Channel
7.4.2.2. France
7.4.2.2.1. France Alopecia Treatment Market, By Drug Type
7.4.2.2.2. France Alopecia Treatment Market, By Indication
7.4.2.2.3. France Alopecia Treatment Market, By Distribution Channel
7.4.2.3. Uk
7.4.2.3.1. Uk Alopecia Treatment Market, By Drug Type
7.4.2.3.2. Uk Alopecia Treatment Market, By Indication
7.4.2.3.3. Uk Alopecia Treatment Market, By Distribution Channel
7.4.2.4. Italy
7.4.2.4.1. Italy Alopecia Treatment Market, By Drug Type
7.4.2.4.2. Italy Alopecia Treatment Market, By Indication
7.4.2.4.3. Italy Alopecia Treatment Market, By Distribution Channel
7.4.2.5. Spain
7.4.2.5.1. Spain Alopecia Treatment Market, By Drug Type
7.4.2.5.2. Spain Alopecia Treatment Market, By Indication
7.4.2.5.3. Spain Alopecia Treatment Market, By Distribution Channel
7.4.2.6. Rest of Europe
7.4.2.6.1. Rest of Europe Alopecia Treatment Market, By Drug Type
7.4.2.6.2. Rest of Europe Alopecia Treatment Market, By Indication
7.4.2.6.3. Rest of Europe Alopecia Treatment Market, By Distribution Channel
7.4.3. Europe Market Size And Forecast, By Drug Type
7.4.4. Europe Market Size And Forecast, By Indication
7.4.5. Europe Market Size And Forecast, By Distribution Channel
7.5. Asia-Pacific
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.2.1. Japan
7.5.2.1.1. Japan Alopecia Treatment Market, By Drug Type
7.5.2.1.2. Japan Alopecia Treatment Market, By Indication
7.5.2.1.3. Japan Alopecia Treatment Market, By Distribution Channel
7.5.2.2. China
7.5.2.2.1. China Alopecia Treatment Market, By Drug Type
7.5.2.2.2. China Alopecia Treatment Market, By Indication
7.5.2.2.3. China Alopecia Treatment Market, By Distribution Channel
7.5.2.3. Australia
7.5.2.3.1. Australia Alopecia Treatment Market, By Drug Type
7.5.2.3.2. Australia Alopecia Treatment Market, By Indication
7.5.2.3.3. Australia Alopecia Treatment Market, By Distribution Channel
7.5.2.4. India
7.5.2.4.1. India Alopecia Treatment Market, By Drug Type
7.5.2.4.2. India Alopecia Treatment Market, By Indication
7.5.2.4.3. India Alopecia Treatment Market, By Distribution Channel
7.5.2.5. South Korea
7.5.2.5.1. South Korea Alopecia Treatment Market, By Drug Type
7.5.2.5.2. South Korea Alopecia Treatment Market, By Indication
7.5.2.5.3. South Korea Alopecia Treatment Market, By Distribution Channel
7.5.2.6. Rest of Asia-Pacific
7.5.2.6.1. Rest of Asia-Pacific Alopecia Treatment Market, By Drug Type
7.5.2.6.2. Rest of Asia-Pacific Alopecia Treatment Market, By Indication
7.5.2.6.3. Rest of Asia-Pacific Alopecia Treatment Market, By Distribution Channel
7.5.3. Asia-Pacific Market Size And Forecast, By Drug Type
7.5.4. Asia-Pacific Market Size And Forecast, By Indication
7.5.5. Asia-Pacific Market Size And Forecast, By Distribution Channel
7.6. Lamea
7.6.1. Key Market Trends, Growth Factors, And Opportunities
7.6.2. Market Size And Forecast, By Country
7.6.2.1. Brazil
7.6.2.1.1. Brazil Alopecia Treatment Market, By Drug Type
7.6.2.1.2. Brazil Alopecia Treatment Market, By Indication
7.6.2.1.3. Brazil Alopecia Treatment Market, By Distribution Channel
7.6.2.2. Saudi Arabia
7.6.2.2.1. Saudi Arabia Alopecia Treatment Market, By Drug Type
7.6.2.2.2. Saudi Arabia Alopecia Treatment Market, By Indication
7.6.2.2.3. Saudi Arabia Alopecia Treatment Market, By Distribution Channel
7.6.2.3. South Africa
7.6.2.3.1. South Africa Alopecia Treatment Market, By Drug Type
7.6.2.3.2. South Africa Alopecia Treatment Market, By Indication
7.6.2.3.3. South Africa Alopecia Treatment Market, By Distribution Channel
7.6.2.4. Rest of Lamea
7.6.2.4.1. Rest of Lamea Alopecia Treatment Market, By Drug Type
7.6.2.4.2. Rest of Lamea Alopecia Treatment Market, By Indication
7.6.2.4.3. Rest of Lamea Alopecia Treatment Market, By Distribution Channel
7.6.3. Lamea Market Size And Forecast, By Drug Type
7.6.4. Lamea Market Size And Forecast, By Indication
7.6.5. Lamea Market Size And Forecast, By Distribution Channel
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
